Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany
Patients with symptomatic obstructive HCM experienced greater clinical and economic burden than asymptomatic patients in Germany.
Authors
- Yue Zhong (ORCID: https://orcid.org/0000-0002-9839-0160)
- Ervant J. Maksabedian Hernandez (ORCID: https://orcid.org/0000-0003-1945-3061)
- Carla L. Zema
- Benjamin Meder (ORCID: https://orcid.org/0000-0003-0741-2633)
- Tobias Bluhmki (ORCID: https://orcid.org/0000-0003-2625-4167)
- Michael Schultze (ORCID: https://orcid.org/0009-0002-1494-5446)
- Farbod Sedaghat‐Hamedani (ORCID: https://orcid.org/0000-0002-3266-0527)
- Nils Kossack (ORCID: https://orcid.org/0000-0002-9521-3898)
- Tarcyane Barata Garcia (ORCID: https://orcid.org/0000-0002-2038-1395)
- Julia Borchert
- Taryn Krause (ORCID: https://orcid.org/0009-0009-5681-8497)
- Johanna Schmoelders
Institutions
- German Society of Surgery (DE)
- Bristol-Myers Squibb (Germany) (DE)
- Heidelberg University (DE)
- Bristol-Myers Squibb (United States) (US)
- Research Institute for System Studies (RU)
- Bristol-Myers Squibb (United Kingdom) (GB)
- German Centre for Cardiovascular Research (DE)
- Berlin Center for Epidemiology and Health Research (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1007/s00392-025-02776-4
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb